AI brief of an SEC Form 8-K · Frontdoor (FTDR)

Frontdoor completes $585 million acquisition of 2-10 Home Buyers Warranty

Neutral Impact 4 of 5 m&a Written later

Frontdoor, Inc. completed its purchase of 2-10 Home Buyers Warranty on December 19, 2024, for $585 million in cash, subject to customary adjustments. The company also entered an amended credit agreement with a $1.47 billion facility to refinance existing debt and fund the deal, with remaining funds planned for share repurchases or general corporate purposes.

Key points

  • Acquisition price: $585 million in all-cash consideration, subject to customary adjustments for cash, debt, working capital and other items at closing
  • New $1.47 billion credit facility: $417.75 million Term A loans (5-year), $800 million Term B loans (7-year), and a $250 million revolving facility
  • Term SOFR plus 1.75% for Revolving and Term A loans and Term SOFR plus 2.25% for Term B loans at the initial rates
  • Company says 2-10 immediately grows its customer base, revenue and earnings, but the filing gives no figures for these effects

The filing

CompanyFrontdoor (FTDR)
Form8-K, current report
Filed with the SECDec 19, 2024, 4:05 PM ET
Accession number0000950170-24-138432

Items reported: 1.01 Material Definitive Agreement2.01 Acquisition or Disposition Completed2.03 New Direct Financial Obligation7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:58 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 19, 2024.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.